FindTrial
Sign In

Effect of Moxifloxacin(0.5mg) instillation in anterior chamber in Phacoemulsification surgery

Effect of intracameral Moxifloxacin(0.5mg)on corneal endothelium in Phacoemulsification surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025909
Enrollment
200
Registered
2020-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: moxifloxacin instillation: effect of intracameral moxifloxacin(0.5mg) during phacoemulsification and without intracameral moxifloxacin Control Intervention1: moxifloxacin instillation:

Sponsors

Mohit kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group (40-80yr) 2. Senile cataract in patients associated with visual impairment. 3. Grade I - III cataract (grading will be done according to LOCS III classification

Exclusion criteria

Exclusion criteria: 1.Patients with any ocular pathology other than cataracts such as retinal vascular disorders and ARMD and Diabetic retinopathy . 2. Ocular condition like glaucoma and uveitis . 3.Those with other media opacities corneal or vitreous . 4.Subjects with traumatic cataract, complicated cataract , grade 4 cataract 5.Patient with known case of diabetes mellitus 6.Patients who underwent previous intraocular surgery other than cataract. 7.Any intraoperative complication 1.Patients with any ocular pathology other than cataracts such as retinal vascular disorders and ARMD and Diabetic retinopathy . 2. Ocular condition like glaucoma and uveitis . 3.Those with other media opacities corneal or vitreous . 4.Subjects with traumatic cataract, complicated cataract , grade 4 cataract 5.Patient with known case of diabetes mellitus 6.Patients who underwent previous intraocular surgery other than cataract. 7.Any intraoperative complication

Design outcomes

Primary

MeasureTime frame
to study the effect of intracameral moxifloxacin(0.5mg) on corneal endothelium in phacoemulsification surgeryTimepoint: Corneal endothelial cell count on day 1, 7 and 21 after surgery.—

Secondary

MeasureTime frame
TO COMPARE THE CHANGE IN MORPHOLOGY OF CORNEA â?? ENDOTHELIAL CELL COUNT , HEXAGONALITY, COEFICIENT OF VARIATION IN CELL AREA, CORNEAL THICKNESS DUE TO USE OF INTRACAMERAL MOXIFLOXACIN IN PHACOEMULSIFICATION SURGERY.Timepoint: day 1, 7 and 21 after surgery—

Countries

India

Contacts

Public ContactDr Mohit Kumar

Government Medical College Haldwani

gstitiyal@yahoo.co.in9412905432

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026